Ultragenyx Pharmaceutical reported $-141593000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -33651000 79.36M
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Aptinyx Inc APTX:US $ -17105000 2.27M
Biocryst Pharmaceuticals BCRX:US $ -34722000 15.24M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bluebird Bio BLUE:US $ -100761000 19.58M
Epizyme EPZM:US $ -29806000 21.12M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Insmed INSM:US $ -100938000 513K
IONIS PHARMACEUT IONS:US $ -85514000 28.01M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Kyowa Hakko Kirin 4151:JP 20.78B 4.67B
Macrogenics MGNX:US $ -41808000 24.83M
Mirati Therapeutics MRTX:US $ -177205000 7.01M
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Puma Biotechnology PBYI:US $ 12.06M 12.8M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M
Vital Therapies VTL:US $ -20610000 825K
Xoma XOMA:US $ -4767000 2.7M